首页> 外国专利> NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF

NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF

机译:新型白介素-17A和白介素23结合多肽及其用途

摘要

The present invention relates to novel, specific-binding therapeutic and/or diagnostic polypeptides directed against the target of Swiss Prot Q16552 and novel, specific-binding therapeutic and/or diagnostic polypeptides directed against the target of Swiss Prot Q9NPF7. In addition, the present invention relates to novel, specific-binding therapeutic and/or diagnostic polypeptides directed against one or both of Swiss Prot Q16552 and Swiss Prot Q9NPF7. The invention also relates to nucleic acid molecules encoding such polypeptides and to methods for generation of such polypeptides and nucleic acid molecules. In addition, the invention is directed to compositions comprising the polypeptides, and therapeutic and/or diagnostic uses of these polypeptides.
机译:本发明涉及针对Swiss Prot Q16552靶标的新颖的,特异性结合的治疗和/或诊断多肽,以及针对Swiss Prot Q9NPF7靶标的新颖的,特异性结合的治疗和/或诊断多肽。另外,本发明涉及针对Swiss Prot Q16552和Swiss Prot Q9NPF7中的一个或两个的新颖的,特异性结合的治疗和/或诊断多肽。本发明还涉及编码此类多肽的核酸分子,并涉及产生此类多肽和核酸分子的方法。另外,本发明涉及包含所述多肽的组合物,以及这些多肽的治疗和/或诊断用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号